Inovio Pharmaceuticals Inc has a consensus price target of $11.86, established from looking at the 16 latest analyst ratings. The last 3 analyst ratings were released from Stephens & Co., Oppenheimer, and RBC Capital on May 14, 2024, March 8, 2024, and March 7, 2024. With an average price target of $23.67 between Stephens & Co., Oppenheimer, and RBC Capital, there's an implied 109.63% upside for Inovio Pharmaceuticals Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|
The latest price target for Inovio Pharmaceuticals (NASDAQ: INO) was reported by Stephens & Co. on May 14, 2024. The analyst firm set a price target for $20.00 expecting INO to rise to within 12 months (a possible 77.15% upside). 5 analyst firms have reported ratings in the last year.
The latest analyst rating for Inovio Pharmaceuticals (NASDAQ: INO) was provided by Stephens & Co., and Inovio Pharmaceuticals initiated their overweight rating.
The last upgrade for Inovio Pharmaceuticals Inc happened on January 25, 2024 when Oppenheimer raised their price target to $4. Oppenheimer previously had a perform for Inovio Pharmaceuticals Inc.
The last downgrade for Inovio Pharmaceuticals Inc happened on November 9, 2022 when Maxim Group changed their price target from N/A to N/A for Inovio Pharmaceuticals Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Inovio Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Inovio Pharmaceuticals was filed on May 14, 2024 so you should expect the next rating to be made available sometime around May 14, 2025.
While ratings are subjective and will change, the latest Inovio Pharmaceuticals (INO) rating was a initiated with a price target of $0.00 to $20.00. The current price Inovio Pharmaceuticals (INO) is trading at is $11.29, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.